Rush University Medical Center's Biennial Cardio-Oncology Symposium 2021
V

Cardiovascular Perspectives on Stem Cell Transplant and CAR T Cell Therapy: The Old and the New for Assessment and Management

By Rush University Medical Center's Biennial Cardio-Oncology Symposium 2021 FEATURING Vlad Zaha
By Rush University Medical Center's Biennial Cardio-Oncology Symposium 2021 FEATURING Vlad Zaha
20 views
January 19, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
07:11
GRACE

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
10:04
University of Colorado Department of Medicine

Cardiotoxicity in Breast Cancer – Case Discussion

Feat. L. Kondapalli
04:08
GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June
06:23
Integrity Continuing Education

ASH 2023 Insights: "PERSEUS Study - Daratumumab With VRd vs. VR…

Feat. O. Landgren
05:47
Meletios Dimopoulos

PERSEUS Study Primary Results: Daratumumab + VRd vs. VRd Alone in Pa…

15:24
Michael Soulen

Interventional Delivery of CAR-T Therapy

05:56
ASH 2022 Conference Coverage

ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalido…

Feat. G. Morgan
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
13:05
Moffitt Cancer Center

Newly Diagnosed Myeloma: Why We Should Use a Response-Adapted Approa…

Feat. K. Shain
18:27
Indy Hematology Review

DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…

Feat. J. Mikhael
52:39
Yale Cancer Center

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Feat. A. Chari
41:54
University of Colorado Division of Hematology

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor
20:25
Andrew Hahn

ADT for Prostate Cancer and Cardiovascular Health Considerations

25:24
Beth Israel Deaconess Medical Center

CAR T-Cell Failure: Mechanisms and Salvage Options

Feat. J. Arnason
21:11
MyCancerHaven

Experts Discuss the Future of Stem Cell Transplantation in Myeloma

Feat. R. Vij, N. Callander
07:01
Total Health

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Feat. I. Rhea